Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice
- PMID: 14534547
- DOI: 10.1038/nature02052
Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice
Abstract
The mouse mutant mnd2 (motor neuron degeneration 2) exhibits muscle wasting, neurodegeneration, involution of the spleen and thymus, and death by 40 days of age. Degeneration of striatal neurons, with astrogliosis and microglia activation, begins at around 3 weeks of age, and other neurons are affected at later stages. Here we have identified the mnd2 mutation as the missense mutation Ser276Cys in the protease domain of the nuclear-encoded mitochondrial serine protease Omi (also known as HtrA2 or Prss25). Protease activity of Omi is greatly reduced in tissues of mnd2 mice but is restored in mice rescued by a bacterial artificial chromosome transgene containing the wild-type Omi gene. Deletion of the PDZ domain partially restores protease activity to the inactive recombinant Omi protein carrying the Ser276Cys mutation, suggesting that the mutation impairs substrate access or binding to the active site pocket. Loss of Omi protease activity increases the susceptibility of mitochondria to induction of the permeability transition, and increases the sensitivity of mouse embryonic fibroblasts to stress-induced cell death. The neurodegeneration and juvenile lethality in mnd2 mice result from this defect in mitochondrial Omi protease.
Similar articles
-
Cyclophilin D-dependent mitochondrial permeability transition is not involved in neurodegeneration in mnd2 mutant mice.Biochem Biophys Res Commun. 2010 Mar 5;393(2):264-7. doi: 10.1016/j.bbrc.2010.01.117. Epub 2010 Feb 1. Biochem Biophys Res Commun. 2010. PMID: 20123086
-
Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi.Nat Struct Biol. 2002 Jun;9(6):436-41. doi: 10.1038/nsb795. Nat Struct Biol. 2002. PMID: 11967569
-
Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways.Cell Death Differ. 2004 Feb;11(2):208-16. doi: 10.1038/sj.cdd.4401343. Cell Death Differ. 2004. PMID: 14605674
-
The mitochondrial serine protease HtrA2/Omi: an overview.Cell Death Differ. 2008 Mar;15(3):453-60. doi: 10.1038/sj.cdd.4402291. Epub 2008 Jan 4. Cell Death Differ. 2008. PMID: 18174901 Review.
-
[Mitochondrial serine protease Omi/HtrA2 and apoptosis].Sheng Li Ke Xue Jin Zhan. 2006 Jul;37(3):285-8. Sheng Li Ke Xue Jin Zhan. 2006. PMID: 17009747 Review. Chinese. No abstract available.
Cited by
-
Structural basis of substrate recognition and allosteric activation of the proapoptotic mitochondrial HtrA2 protease.Nat Commun. 2024 May 30;15(1):4592. doi: 10.1038/s41467-024-48997-5. Nat Commun. 2024. PMID: 38816423
-
Exploring the dietary strategies of phenylalanine: Improving muscle nutraceutical quality as well as muscle glycogen and protein deposition in adult grass carp (Ctenopharyngodon idella).Food Chem X. 2024 Apr 27;22:101421. doi: 10.1016/j.fochx.2024.101421. eCollection 2024 Jun 30. Food Chem X. 2024. PMID: 38756468 Free PMC article.
-
Cytosolic retention of HtrA2 during mitochondrial protein import stress triggers the DELE1-HRI pathway.Commun Biol. 2024 Mar 30;7(1):391. doi: 10.1038/s42003-024-06107-7. Commun Biol. 2024. PMID: 38555279 Free PMC article.
-
HTRA2/OMI-Mediated Mitochondrial Quality Control Alters Macrophage Polarization Affecting Systemic Chronic Inflammation.Int J Mol Sci. 2024 Jan 27;25(3):1577. doi: 10.3390/ijms25031577. Int J Mol Sci. 2024. PMID: 38338855 Free PMC article. Review.
-
Protease-independent control of parthanatos by HtrA2/Omi.Cell Mol Life Sci. 2023 Aug 18;80(9):258. doi: 10.1007/s00018-023-04904-7. Cell Mol Life Sci. 2023. PMID: 37594630 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases